Stephens Inc Organon & Co. Transaction History

Stephens Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $40,098 - $57,452	-2,417 Reduced 15.98%	12,711 $220,000
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $100,184 - $128,051	-5,199 Reduced 25.58%	15,128 $314,000
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $148,590 - $222,538	-6,937 Reduced 25.44%	20,327 $478,000
Q4 2022 Jan 25, 2023	SELL	$23.31 - $28.61 $61,328 - $75,272	-2,631 Reduced 8.8%	27,264 $761,000
Q3 2022 Nov 02, 2022	BUY	$23.4 - $34.25 $6,669 - $9,761	285 Added 0.96%	29,895 $700,000
Q2 2022 Aug 03, 2022	SELL	$31.66 - $38.9 $110,335 - $135,566	-3,485 Reduced 10.53%	29,610 $999,000
Q1 2022 May 04, 2022	SELL	$30.45 - $39.36 $475,172 - $614,212	-15,605 Reduced 32.04%	33,095 $1.16 Million
Q4 2021 Mar 07, 2022	BUY	$28.67 - $37.13 $160,437 - $207,779	5,596 Added 12.98%	48,700 $1.48 Million
Q3 2021 Oct 27, 2021	BUY	$28.63 - $35.64 $235,481 - $293,139	8,225 Added 23.58%	43,104 $1.41 Million
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $992,307 - $1.33 Million	34,879 New	34,879 $1.06 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.06B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.